“Our goal is to accelerate the Botanical Synthesis movement that our team has wholly dedicated themselves to – driving forward innovation, our...
Read MoreBIOHARVEST SCIENCES INC. ANNOUNCES RESIGNATION OF LIRON CARMEL
January 11, 2022
Vancouver, BC / January 10, 2022 / BioHarvest Sciences Inc. (the “Company”, “BioHarvest”) (CSE: BHSC) announces today that Liron Carmel has resigned as a member of the Company’s Board of Directors.
Dr. Zaki Rakib, Chairman of the board, said “on behalf of the board of directors, I want to thank Liron for his contribution to the governance of BioHarvest during his service on the board. As announced when Mr. David Tsur joined the board in October 2021, the Company will continue to enhance the board with members bringing expertise in Biotech”.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit:www.bioharvest.com.
Our Blog
Are depleted soils depleting the benefits of fruits and vegetables?
By Dr. Brian Cornblatt Over the past 50 years there has been a paradigm shift in dietary preferences. The proverbial meat and potatoes —once...
Read MoreAbout BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals – nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API’s) that focus on specific medical indications.
